As we approach December, all eyes are on Check Cap (NASDAQ: CHEK), a prominent player in the Healthcare sector, specifically in the Health Care Equipment & Supplies industry. The company, known for its innovative approach in Diagnostics & Research, has been under the microscope due to its financial performance
. Despite reporting a net income loss of $19.1 million
and an operating income loss of $20 million, the company's book value stands at a respectable $5.16.